|Mr. Cam L. Garner||Co-Founder & Chairperson||42.5k||N/A||1948|
|Mr. David A. Gonyer R.Ph.||Chief Exec. Officer, Pres & Director||631.95k||N/A||1964|
|Mr. Matthew J. D'Onofrio MBA||Co-Founder, Chief Bus. Officer, Exec. VP, Treasurer & Sec.||491k||N/A||1970|
|Dr. Marilyn R. Carlson D.M.D., M.D., RAC.||Chief Medical Officer||423.5k||N/A||1948|
|Dr. Wayne Alves Ph.D.||Sr. Director of Clinical Operations||N/A||N/A||N/A|
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray, which completed Phase III clinical trials for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The company was founded in 2007 and is headquartered in Solana Beach, California.
Evoke Pharma, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.